$SGRY News

TD Cowen Maintains Buy on Surgery Partners, Raises Price Target to $19

RBC Capital Maintains Outperform on Surgery Partners, Lowers Price Target to $19

Cantor Fitzgerald Reiterates Overweight on Surgery Partners, Maintains $18 Price Target

Surgery Partners, Inc. 2026 Q2 - Results - Earnings Call Presentation

Surgery Partners, Inc. (SGRY) Q2 2026 Earnings Call Transcript

Surgery Partners Q2 Adj. EPS $0.10 Beats $0.06 Estimate, Sales $848.900M Beat $830.366M Estimate

Surgery Partners Affirms FY2026 Sales Guidance of $3.350B-$3.450B vs $3.408B Est

Strength Seen in Surgery Partners (SGRY): Can Its 5.3% Jump Turn into More Strength?

Surgery Partners Announces Entry Into Agreement to Sell Ownership Interests in Idaho Falls Facilities to Intermountain Health; Reaffirms Guidance, Excluding Impact of Transaction

Surgery Partners Monetizes Idaho Assets As It Chases Faster Growth

Surgery Partners Affirms FY2026 Sales Guidance of $3.350B-$3.450B vs $3.408B Est

Surgery Partners To Sell Ownership Interests In Mountain View Hospital And Idaho Falls Community Hospital To Intermountain Health; Deal Values Combined Idaho Falls Facilities At ~$1.15B, Total Consideration To Surgery Partners ~$795M

Surgery Partners (SGRY) Could Be 9% Undervalued As Outpatient Surgery Growth Narrative Builds

Fast-paced Momentum Stock Surgery Partners (SGRY) Is Still Trading at a Bargain

Why Surgery Partners (SGRY) Stock Is Trading Up Today

Why Fast-paced Mover Surgery Partners (SGRY) Is a Great Choice for Value Investors

Unpacking Q1 Earnings: Surgery Partners (NASDAQ:SGRY) In The Context Of Other Outpatient & Specialty Care Stocks

Wall Street Analysts See a 26.14% Upside in Surgery Partners (SGRY): Can the Stock Really Move This High?

3 Reasons to Sell SGRY and 1 Stock to Buy Instead

Is Surgery Partners’ (SGRY) Q1 Beat And Reaffirmed 2026 Outlook Altering The Investment Case?